Results 181 to 190 of about 484,364 (380)
Estrogen treatment for cancer of the prostate.Early results with 3 doses of diethylstilbestrol and placebo [PDF]
John C. Bailar, David P. Byar
openalex +1 more source
Objective The SEMAPHORE trial evaluated the efficacy and safety of tocilizumab (TCZ) treatment in patients with glucocorticoid (GC)‐dependent polymyalgia rheumatica (PMR). TCZ reduced GC dose and disease activity at week 24. This study aimed to assess relapse rates after stopping TCZ treatment in patients achieving remission at week 24.
Baptiste Chevet+24 more
wiley +1 more source
Jason El Brihi, R. Horne, Kate Faasse
semanticscholar +1 more source
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek+7 more
wiley +1 more source
Background and Aim: Intense exercise can cause damages caused by oxidative stress and inflammation and, as a result, reduce exercise performance. The present study aimed at determining the effect of barberry juice supplement on the inflammation caused by
Babak Hooshmand Moghadam+2 more
doaj
Problems in deceptive medical procedures: an ethical and legal analysis of the administration of placebos [PDF]
Beth A. Simmons
openalex +1 more source
Objectives Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of dotinurad with febuxostat in Chinese patients with gout. Methods This phase 3, multicentre, randomised, double‐blind, parallel‐group study randomly allocated (1:1) eligible patients with gout to receive oral dotinurad
Jia Sun+19 more
wiley +1 more source
Talking placebo: a qualitative study of patients' attitudes toward open-label placebo implementation into clinical practice. [PDF]
Frey Nascimento A+8 more
europepmc +1 more source
Objective We used data from the placebo arm of the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD ...
Shervin Assassi+6 more
wiley +1 more source